Data / Form D filings / Gibson Oncology, LLC
Gibson Oncology, LLC: Form D filings
Gibson Oncology, LLC, a biotechnology company in Miami, FL, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on July 21, 2025, reports $250,000 sold of a $1.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7772 FISHER ISLAND DRIVE, Miami, FL, 33109
- Phone
- (502) 345-8911
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2042777
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | New notice | $1,500,000 | $250,000 | $1,250,000 | 1 | Jul 7, 2025 | sec.gov |
| Oct 31, 2024 | New notice | $4,725,000 | $3,800,000 | $925,000 | 8 | Apr 23, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Cushman | Director | |
| Clifford Solomon | Executive Officer, Director | |
| Elizabeth Rogers | Executive Officer, Director | |
| Mark Rogers | Director | |
| Theodore Solomon | Executive Officer, Director | |
| Randall Riggs | Executive Officer, Director | |
| Mark Baganz | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Jul 21, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gibson Oncology, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.